Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
ANIMAL VIRUSES

The Nucleoside Triphosphatase and Helicase Activities of Vaccinia Virus NPH-II Are Essential for Virus Replication

Christian H. Gross, Stewart Shuman
Christian H. Gross
Molecular Biology Program, Sloan-Kettering Institute, New York, New York 10021
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stewart Shuman
Molecular Biology Program, Sloan-Kettering Institute, New York, New York 10021
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.72.6.4729-4736.1998
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Fig. 1.
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Conserved sequence elements define the DExH protein family. The amino acid sequence of motifs I, Ia, II, III, and VI of vaccinia virus NPH-II (GenBank accession no. M35027 ) is aligned with the sequences (with GenBank accession numbers in parentheses) of the corresponding motifs of six other DExH-box proteins: human helicase A (Hel-A) (L13848 ); Saccharomyces cerevisiae splicing factors Prp2 (X55936 ), Prp16 (M31524 ), and Prp22 (X58681 );Drosophila MLE protein (M7412); and HCV RNA helicase NS3 (M62385 ). Amino acids that have been shown by mutagenesis to be important for the ATPase or helicase activities of NPH-II are shown in shaded boxes. New residues mutated in this study are marked by asterisks.

  • Fig. 2.
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    NPH-II purification. Aliquots (0.23 μg) of the glycerol gradient preparations of wild-type (WT) NPH-II and the indicated NPH-II-Ala mutants were electrophoresed through an 8% polyacrylamide gel containing 0.1% SDS. Polypeptides were visualized by staining with Coomassie blue dye. The positions and sizes (in kilodaltons) of marker proteins are indicated at the left. The polypeptide corresponding to NPH-II is indicated by the arrow on the right.

  • Fig. 3.
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    RNA unwinding by wild-type and mutant NPH-II proteins. Helicase assays were performed as described in Materials and Methods. The extent of RNA unwinding by wild-type (WT) and mutated NPH-II proteins is plotted as a function of the amount of input enzyme. Each data point represents the average of two independent determinations. The source of the protein preparation is indicated in the key to symbols.

  • Fig. 4.
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Binding of wild-type and mutated His-NPH-II proteins to ssRNA. Binding of NPH-II to a radiolabeled 98-mer ssRNA was measured in a gel shift assay as described in Materials and Methods. The extent of protein-RNA complex formation is plotted as a function of input enzyme. The symbols denoting identities of the proteins used in the titration experiments are as shown in Fig. 3.

  • Fig. 5.
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    ATP hydrolysis by wild-type (WT) and mutated His-NPH-II proteins. ATP hydrolysis by NPH-II in the presence of single-stranded M13mp18 DNA was assayed as described elsewhere (8). ATPase activity is expressed as nanomoles of 32Pireleased from [γ32P]ATP during a 30-min incubation at 37°C and is plotted as a function of input enzyme. Each data point represents the average of two independent determinations. The protein preparations used for each titration experiment are indicated in the key to symbols.

  • Fig. 6.
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    Genotyping of rescued viruses. (A) Summary of viral genotypes determined by restriction analysis of PCR-amplified NPH-II genes from plaque-purified virus revertants. WT, wild type. (B) Genotyping by restriction digestion. Representative restriction endonuclease digests were analyzed by agarose gel electrophoresis. The NPH-II gene was PCR amplified from DNA isolated from cells infected with wild-type vaccinia virus or plaque-purified revertants recovered after transfection with the indicated NPH-II-Ala genes. The 1,718-bp PCR products were digested with restriction endonucleaseAsp718 (lanes 1 and 2), AvrII (lanes 3, 4, 9, 10, and 11), BstNI (lanes 5, 6, 12, 13, and 14), orEagI (lanes 15 to 17). For those transfections where the mutant allele was not incorporated into any rescued viruses (R229A, G502A, and T328A), a control restriction digest was performed with the 1,718-bp PCR product amplified from the pTM-based plasmid containing the indicated alanine substitution (lanes 11, 14, and 17). DNA was visualized by staining the agarose gel with ethidium bromide. The positions and sizes (in base pairs) of linear DNA markers are indicated on the left. The 1.7-kbp PCR fragment is depicted as a horizontal bar. The locations of the restriction sites within the wild-type NPH-II gene are denoted below the bar. The Q194A mutation eliminates theAsp718 site. The P228A and R229A mutations destroy theAvrII site. The N500A, P501A, and G502A mutations eliminate the downstream BstNI site. The T328A mutation creates a unique EagI site; digestion at this site (indicated by the arrow above the bar) generates a doublet of 877- and 841-bp fragments.

Tables

  • Figures
  • Table 1.

    Rescue of ts10 by NPH-II alleles containing alanine mutations in motifs II and III

    NPH-II geneVirus titer at 40°C (PFU/ml)Sp activity of protein (% of wild-type activity)
    ATPaseHelicase
    Wild type1 × 107 100100
    D296A2 × 104 5 a <5 a
    E297A3 × 104 5 a <5 a
    H299A3 × 104 58<1
    E300A1 × 104 1<1
    T326A1 × 104 51<1
    T328A1 × 104 521
    Plasmid<10
    • ↵a From reference 8.

  • Table 2.

    Rescue of ts18 by NPH-II alleles containing alanine mutations in motifs I and Ia

    NPH-II geneVirus titer at 40°C (PFU/ml)Sp activity of protein (% of wild-type activity)
    ATPaseHelicase
    Wild type2 × 107 100100
    T187A3 × 106 6852
    T192A4 × 104 <0.2<1
    Q194A2 × 106 5546
    P228A8 × 105 9121
    R229A2 × 104 2<1
    Plasmid<10
  • Table 3.

    Rescue of ts39 by NPH-II alleles containing alanine mutations in motifs VI

    NPH-II geneVirus titer at 40°C (PFU/ml)Sp activity of proteina (% of wild-type activity)
    ATPaseHelicase
    Wild type8 × 106 100100
    Q491A1 × 104 92
    G494A1 × 104 106
    R495A1 × 104 37
    G497A1 × 104 1810
    R498A1 × 104 37
    N500A8 × 106 100100
    P501A5 × 106 100100
    G502A6 × 103 186
    Plasmid<10
    • ↵a From reference 9.

PreviousNext
Back to top
Download PDF
Citation Tools
The Nucleoside Triphosphatase and Helicase Activities of Vaccinia Virus NPH-II Are Essential for Virus Replication
Christian H. Gross, Stewart Shuman
Journal of Virology Jun 1998, 72 (6) 4729-4736; DOI: 10.1128/JVI.72.6.4729-4736.1998

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Nucleoside Triphosphatase and Helicase Activities of Vaccinia Virus NPH-II Are Essential for Virus Replication
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Nucleoside Triphosphatase and Helicase Activities of Vaccinia Virus NPH-II Are Essential for Virus Replication
Christian H. Gross, Stewart Shuman
Journal of Virology Jun 1998, 72 (6) 4729-4736; DOI: 10.1128/JVI.72.6.4729-4736.1998
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Acid Anhydride Hydrolases
RNA Nucleotidyltransferases
vaccinia virus
virus replication

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514